5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine

Catalog No. :
ACYMAQ901
CAS No. :
908269-41-0
Molecular Formula :
C6H9N3S
Molecular Weight :
155.05

IUPAC Name:5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine

5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
100mg95%$157.00Login to see priceIn stockInquiry
250mg95%$296.00Login to see priceIn stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine
IUPAC Name5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine
MDL No.0
Molecular FormulaC6H9N3S
Molecular Weight155.05
SMILESNC1=NN=C(C2(CC2)C)S1
InChI KeyYLCDVSLTWVMHOW-UHFFFAOYSA-N
Synonym1,3,4-Thiadiazol-2-amine, 5-(1-methylcyclopropyl)-;5-(1-methylcyclopropyl)-1,3,4-thiadiazol-2-amine;2-Amino-5-(1-methylcyclopropyl)-1,3,4-thiadiazole
CAS No.908269-41-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H312-H315-H319-H332-H335
Precautionary Statement(s)
P261-P264-P270-P271-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACYMAQ901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMEU152 route compound structure diagram
    ACRMEU1526914-76-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACYMAQ901 route product structure diagram
    ACYMAQ901908269-41-0 In Stock
Inquiry

2. ACYMAQ901 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACRMEU152 route compound structure diagram
    ACRMEU1526914-76-7 In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Plus
  5. reactant_3 route compound structure diagram
    --
  6. Then
  7. ACYMAQ901 route product structure diagram
    ACYMAQ901908269-41-0 In Stock
Inquiry

Comments (0)